Expression of glutamate carboxypeptidase II in human brain

Neuroscience

Volumn 144, Issue 4, 2007, Pages 1361-1372

  Sacha P ^a,b   Zamecnik J ^b   Barinka C ^a   Hlouchova K ^a,b   Vicha A ^b   Mlcochova P ^a,b   Hilgert, I ^c   Eckschlager, T ^b   Konvalinka, J ^a,b  

^a INSTITUTE OF MATHEMATICS   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

Author keywords

epitope mapping; immunohistochemistry; metallopeptidase; NAALADase; prostate cancer; PSMA

Indexed keywords

7E11 ANTIBODY; ANTIBODY; EPITOPE; FOLIC ACID; GAMMA GLUTAMYL HYDROLASE; GLUTAMATE CARBOXYPEPTIDASE II; GLUTAMATE CARBOXYPEPTIDASE III; GLUTAMIC ACID; GLYCOPROTEIN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY GCP 04; N ACETYLASPARTYLGLUTAMIC ACID; PROSTATE SPECIFIC MEMBRANE ANTIGEN; PTEROPTIN; RECOMBINANT PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANTIBODY SPECIFICITY; ARTICLE; ASTROCYTE; BRAIN TISSUE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; EPILEPSY; FEMALE; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; HYDROLYSIS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; ISOTOPE LABELING; JEJUNUM; MALE; NEUROPROTECTION; NEUROTOXICITY; PRIORITY JOURNAL; PROSTATE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SCHIZOPHRENIA; STROKE; TISSUE CULTURE; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ANTIBODIES; ANTIGENS, SURFACE; ASTROCYTES; BLOTTING, WESTERN; BRAIN; DIPEPTIDES; ENZYME ACTIVATION; EPITOPE MAPPING; FEMALE; GLUTAMATE CARBOXYPEPTIDASE II; GLUTAMIC ACID; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MODELS, MOLECULAR; PROTEIN STRUCTURE, TERTIARY; RADIOLIGAND ASSAY; RECOMBINANT FUSION PROTEINS;

EID: 33846308878     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.10.022     Document Type: Article

References (42)

1. Bacich D.J., Ramadan E., O'Keefe D.S., Bukhari N., Wegorzewska I., Ojeifo O., Olszewski R., Wrenn C.C., Bzdega T., Wroblewska B., Heston W.D., and Neale J.H. Deletion of the glutamate carboxypeptidase II gene in mice reveals a second enzyme activity that hydrolyzes N-acetylaspartylglutamate. J Neurochem 83 (2002) 20-29
2. Barinka C., Rinnova M., Sacha P., Rojas C., Majer P., Slusher B.S., and Konvalinka J. Substrate specificity, inhibition and enzymological analysis of recombinant human glutamate carboxypeptidase II. J Neurochem 80 (2002) 477-487
3. Barinka C., Mlcochova P., Sacha P., Hilgert I., Majer P., Slusher B.S., Horejsi V., and Konvalinka J. Amino acids at the N- and C-termini of human glutamate carboxypeptidase II are required for enzymatic activity and proper folding. Eur J Biochem 271 (2004) 2782-2790
4. Barinka C., Sacha P., Sklenar J., Man P., Bezouska K., Slusher B.S., and Konvalinka J. Identification of the N-glycosylation sites on glutamate carboxypeptidase II necessary for proteolytic activity. Protein Sci 13 (2004) 1627-1635
5. Berger U.V., Carter R.E., and Coyle J.T. The immunocytochemical localization of N-acetylaspartyl glutamate, its hydrolysing enzyme NAALADase, and the NMDAR-1 receptor at a vertebrate neuromuscular junction. Neuroscience 64 (1995) 847-850
6. Berger U.V., Luthi-Carter R., Passani L.A., Elkabes S., Black I., Konradi C., and Coyle J.T. Glutamate carboxypeptidase II is expressed by astrocytes in the adult rat nervous system. J Comp Neurol 415 (1999) 52-64
7. Blakely R.D., Robinson M.B., Thompson R.C., and Coyle J.T. Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate: subcellular and regional distribution, ontogeny, and the effect of lesions on N-acetylated-alpha-linked acidic dipeptidase activity. J Neurochem 50 (1988) 1200-1209
8. Bzdega T., Turi T., Wroblewska B., She D.W., Chung H.S., Kim H., and Neale J.H. Molecular cloning of a peptidase against N-acetylaspartylglutamate from a rat hippocampal cDNA library. J Neurochem 69 (1997) 2270-2277
9. Bzdega T., Crowe S.L., Ramadan E.R., Sciarretta K.H., Olszewski R.T., Ojeifo O.A., Rafalski V.A., Wroblewska B., and Neale J.H. The cloning and characterization of a second brain enzyme with NAAG peptidase activity. J Neurochem 89 (2004) 627-635
10. Carter R.E., Feldman A.R., and Coyle J.T. Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase. Proc Natl Acad Sci U S A 93 (1996) 749-753
11. Chang S.S., Reuter V.E., Heston W.D., Bander N.H., Grauer L.S., and Gaudin P.B. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. Cancer Res 59 (1999) 3192-3198
12. Davis M.I., Bennett M.J., Thomas L.M., and Bjorkman P.J. Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase. Proc Natl Acad Sci U S A 102 (2005) 5981-5986
13. Fuhrman S., Palkovits M., Cassidy M., and Neale J.H. The regional distribution of N-acetylaspartylglutamate (NAAG) and peptidase activity against NAAG in the rat nervous system. J Neurochem 62 (1994) 275-281
14. Ghadge G.D., Slusher B.S., Bodner A., Dal Canto M., Wozniak K., Thomas A.G., Rojas C., Tsukamoto T., Majer P., Miller R.J., Monti A.L., and Roos R.P. Glutamate carboxypeptidase II inhibition protects motor neurons from death in familial amyotrophic lateral sclerosis models. Proc Natl Acad Sci U S A 100 (2003) 9554-9559
15. Ghosh A., and Heston W.D. Effect of carbohydrate moieties on the folate hydrolysis activity of the prostate specific membrane antigen. Prostate 57 (2003) 140-151
16. Halsted C.H., Ling E.H., Luthi-Carter R., Villanueva J.A., Gardner J.M., and Coyle J.T. Folylpoly-gamma-glutamate carboxypeptidase from pig jejunum. Molecular characterization and relation to glutamate carboxypeptidase II. J Biol Chem 273 (1998) 20417-20424
17. Horoszewicz J.S., Kawinski E., and Murphy G.P. Monoclonal-antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic-cancer patients. Anticancer Res 7 (1987) 927-936
18. Huang X.M., Bennett M., and Thorpe P.E. Anti-tumor effects and lack of side effects in mice of an immunotoxin directed against human and mouse prostate-specific membrane antigen. Prostate 61 (2004) 1-11
19. Israeli R.S., Powell C.T., Corr J.G., Fair W.R., and Heston W.D.W. Expression of the prostate-specific membrane antigen. Cancer Res 54 (1994) 1807-1811
20. Jackson P.F., Tays K.L., Maclin K.M., Ko Y.S., Li W., Vitharana D., Tsukamoto T., Stoermer D., Lu X.C., Wozniak K., and Slusher B.S. Design and pharmacological activity of phosphinic acid based NAALADase inhibitors. J Med Chem 44 (2001) 4170-4175
21. Lopes A.D., Davis W.L., Rosenstraus M.J., Uveges A.J., and Gilman S.C. Immunohistochemical and pharmacokinetic characterization of the site-specific immunoconjugate Cyt-356 derived from antiprostate monoclonal antibody-7E11-C5. Cancer Res 50 (1990) 6423-6429
22. Lu X.M., Tang Z., Liu W., Lin Q., and Slusher B.S. N-acetylaspartylglutamate protects against transient focal cerebral ischemia in rats. Eur J Pharmacol 408 (2000) 233-239
23. Luthi-Carter R., Berger U.V., Barczak A.K., Enna M., and Coyle J.T. Isolation and expression of a rat brain cDNA encoding glutamate carboxypeptidase II. Proc Natl Acad Sci U S A 95 (1998) 3215-3220
24. Luthi-Carter R., Barczak A.K., Speno H., and Coyle J.T. Molecular characterization of human brain N-acetylated alpha- linked acidic dipeptidase (NAALADase). J Pharmacol Exp Ther 286 (1998) 1020-1025
25. Mesters J.R., Barinka C., Li W., Tsukamoto T., Majer P., Slusher B.S., Konvalinka J., and Hilgenfeld R. Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer. EMBO J 25 (2006) 1375-1384
26. Murphy G.P. Radioscintiscanning of prostate-cancer. Cancer 75 (1995) 1819-1822
27. Murphy G.P., Su S., Jarisch J., and Kenny G.M. Serum levels of PSMA [letter]. Prostate 42 (2000) 318-319
28. Neale J.H., Bzdega T., and Wroblewska B. N-Acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system. J Neurochem 75 (2000) 443-452
29. Neale J.H., Olszewski R.T., Gehl L.M., Wroblewska B., and Bzdega T. The neurotransmitter N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophrenia. Trends Pharmacol Sci 26 (2005) 477-484
30. O'Keefe D.S., Bacich D.J., and Heston W.D.W. Comparative analysis of prostate-specific membrane antigen (PSMA) versus a prostate-specific membrane antigen-like gene. Prostate 58 (2004) 200-210
31. Pangalos M.N., Neefs J.M., Somers M., Verhasselt P., Bekkers M., van der Helm L., Fraiponts E., Ashton D., and Gordon R.D. Isolation and expression of novel human glutamate carboxypeptidases with N-acetylated alpha-linked acidic dipeptidase and dipeptidyl peptidase IV activity. J Biol Chem 274 (1999) 8470-8483
32. Renneberg H., Friedetzky A., Konrad L., Kurek R., Weingartner K., Wennemuth G., Tunn U.W., and Aumuller G. Prostate specific membrane antigen (PSM) is expressed in various human tissues: implication for the use of PSM reverse transcription polymerase chain reaction to detect hematogenous prostate cancer spread. Urol Res 27 (1999) 23-27
33. Robinson M.B., Blakely R.D., Couto R., and Coyle J.T. Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate. Identification and characterization of a novel N-acetylated alpha-linked acidic dipeptidase activity from rat brain. J Biol Chem 262 (1987) 14498-14506
34. Silver D.A., Pellicer I., Fair W.R., Heston W.D., and Cordon-Cardo C. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res 3 (1997) 81-85
35. Slusher B.S., Tsai G., Yoo G., and Coyle J.T. Immunocytochemical localization of the N-acetyl-aspartyl- glutamate (NAAG) hydrolyzing enzyme N-acetylated alpha-linked acidic dipeptidase (NAALADase). J Comp Neurol 315 (1992) 217-229
36. Slusher B.S., Vornov J.J., Thomas A.G., Hurn P.D., Harukuni I., Bhardwaj A., Traystman R.J., Robinson M.B., Britton P., Lu X.C., Tortella F.C., Wozniak K.M., Yudkoff M., Potter B.M., and Jackson P.F. Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury. Nat Med 5 (1999) 1396-1402
37. Sokoloff R.L., Norton K.C., Gasior C.L., Marker K.M., and Grauer L.S. A dual-monoclonal sandwich assay for prostate-specific membrane antigen: levels in tissues, seminal fluid and urine. Prostate 43 (2000) 150-157
38. Su S.L., Huang I.P., Fair W.R., Powell C.T., and Heston W.D. Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression. Cancer Res 55 (1995) 1441-1443
39. Troyer J.K., Beckett M.L., and Wright Jr. G.L. Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids. Int J Cancer 62 (1995) 552-558
40. Tsai G.C., Stauch-Slusher B., Sim L., Hedreen J.C., Rothstein J.D., Kuncl R., and Coyle J.T. Reductions in acidic amino-acids and N-acetylaspartylglutamate in amyotrophic-lateral-sclerosis CNS. Brain Res 556 (1991) 151-156
41. Wroblewska B., Wroblewski J.T., Pshenichkin S., Surin A., Sullivan S.E., and Neale J.H. N-acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells. J Neurochem 69 (1997) 174-181
42. Yamamoto T., Hirasawa S., Wroblewska B., Grajkowska E., Zhou J., Kozikowski A., Wroblewski J., and Neale J.H. Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model. Eur J Neurosci 20 (2004) 483-494